These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32013983)

  • 21. Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases.
    Johnson K; Guo C; Gosink M; Wang V; Hauben M
    Bioinformatics; 2012 Dec; 28(23):3123-30. PubMed ID: 23064001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Authenticity and credibility aware detection of adverse drug events from social media.
    Hoang T; Liu J; Pratt N; Zheng VW; Chang KC; Roughead E; Li J
    Int J Med Inform; 2018 Dec; 120():157-171. PubMed ID: 30409341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Authenticity and credibility aware detection of adverse drug events from social media.
    Hoang T; Liu J; Pratt N; Zheng VW; Chang KC; Roughead E; Li J
    Int J Med Inform; 2018 Dec; 120():101-115. PubMed ID: 30409335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
    Castillon G; Salvo F; Moride Y
    Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation.
    Dupuch M; Grabar N
    J Biomed Inform; 2015 Apr; 54():174-85. PubMed ID: 25659451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
    Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
    Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases.
    Seabroke S; Candore G; Juhlin K; Quarcoo N; Wisniewski A; Arani R; Painter J; Tregunno P; Norén GN; Slattery J
    Drug Saf; 2016 Apr; 39(4):355-64. PubMed ID: 26748507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of measures of disproportionality in pharmacovigilance: three Dutch examples.
    Egberts AC; Meyboom RH; van Puijenbroek EP
    Drug Saf; 2002; 25(6):453-8. PubMed ID: 12071783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms.
    Hauben M; Reich L; Chung S
    Eur J Clin Pharmacol; 2004 Dec; 60(10):747-50. PubMed ID: 15619136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China.
    Hou Y; Ye X; Wu G; Cheng G; Du X; He J
    Expert Opin Drug Saf; 2014 Jul; 13(7):853-7. PubMed ID: 24918197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A web-based quantitative signal detection system on adverse drug reaction in China.
    Li C; Xia J; Deng J; Chen W; Wang S; Jiang J; Chen G
    Eur J Clin Pharmacol; 2009 Jul; 65(7):729-41. PubMed ID: 19263045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Database size and power to detect safety signals in pharmacovigilance.
    Hammond IW; Gibbs TG; Seifert HA; Rich DS
    Expert Opin Drug Saf; 2007 Nov; 6(6):713-21. PubMed ID: 17967160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
    Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of data on capecitabine-related adverse drug reactions from the Korean adverse event reporting system database.
    Park JY
    Eur J Oncol Nurs; 2018 Jun; 34():55-60. PubMed ID: 29784139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The upper bound to the Relative Reporting Ratio-a measure of the impact of the violation of hidden assumptions underlying some disproportionality methods used in signal detection.
    Van Holle L; Bauchau V
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):787-94. PubMed ID: 24395594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychiatric adverse drug reactions in the paediatric population.
    Ekhart C; Vries T; Hunsel FV
    Arch Dis Child; 2020 Aug; 105(8):749-755. PubMed ID: 32060030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Information on adverse drug reactions-Proof of principle for a structured database that allows customization of drug information.
    Kusch MKP; Zien A; Hachenberg C; Haefeli WE; Seidling HM
    Int J Med Inform; 2020 Jan; 133():103970. PubMed ID: 31704490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of statistical shrinkage parameters of disproportionality methods in spontaneous reporting system of China.
    Wang J; Ye XF; Guo XJ; Zhu TT; Qi N; Hou YF; Zhang TY; Shi WT; Wei X; Liu YZ; Wu GZ; He J
    Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):962-70. PubMed ID: 26095121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.